Diagnostics For The Development Suppliers For Served Medical Health Care Medical Research

Fapon Biotech Inc., founded in 2001, adheres to the mission of “Enable Disease Identification Earlier, More Accurate, Convenient and Affordable”, while focusing on the future needs and trends of biotechnology development, and committed to providing ...

A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. ...

We specialise in the development and production of innovative parameters and detection methods for laboratory diagnostics and medical research. Our focus is the development of immunological detection methods for unoccupied niches. The products from ...

Together, we drive innovation in molecular diagnostics! Our team of highly skilled chemists, biologists and physicists with extensive experience in developing molecular technologies is dedicated to improve fast diagnostics and further develop our ...

We are a Boston-based company developing precision diagnostics for infectious diseases. Selux’s interdisciplinary team has expertise in microbiology, biochemistry, chemistry, engineering, software, and algorithm design and is buttressed by ...

An advanced diagnostic platform that leverages artificial intelligence (AI) enabled tissue analysis and 3D imaging to reliably detect precancerous cells. CDx provides an integrated solution of enhanced tissue sampling and an AI-assisted diagnostic ...

Cell Culture Company delivers whole cell pellets, cell lysates, custom monoclonal antibody and recombinant protein manufacturing services from development to commercialization. We employ traditional cell culture methods as well as automated, ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as ...

3Helix develops and markets a novel collagen targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology and to develop diagnostics and therapeutics for diseases with high collagen remodeling ...

C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...

“Lytech” Co. Ltd. was established in 1992 as a Research and Production Company on the basis of Scientific Research Institute of Physical-Chemical Medicine. “Lytech” was one of the first companies in Russia which introduced a polymerase chain ...

Novel point-of-care diagnostics for earlier disease detection. SANO Diagnostics is developing a range of disposable, cost-effective point-of-care diagnostics to detect the early onset of inflammation in several disease states. We are a development ...

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA ...

Pishtaz Teb Zaman Diagnostics, started its research, development, and marketing activities in 1998, and rapidly grew to be an international brand specialized in 'In-Vitro Diagnostics Medical Devices and Clinical research'. Our range of products are ...

Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...

Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...

Auspex Diagnostics focuses on developing and providing advanced cancer diagnostics services to medical professionals and patients to help them personalize cancer treatment plans and improve patients’ quality of living. We started developing the ...

SBI is a small biotech company that’s delivered innovative products and services for molecular and cell biology research since January 2004, when we sold our first lentivectors and pPACK lentivirus packaging systems. We focus on being the first ...

Cleveland Diagnostics, Inc. is a commercial-stage diagnostics company developing highly efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. The Company’s Solvent Interaction Analysis ...